The effect of weight reduction diet on C-reactive protein level in obese-adult subjects

Journal of Medical Sciences

Volumn 9, Issue 1, 2009, Pages 17-23

  Al Hamdan, Adel A ^a   Al Huthail, Rabba H ^a   Alasaif, Mohamed A ^a   Al Othman, Abdulaziz M ^a   Al Muammer, May N ^a   Al Orf, Saada M ^a   Saeed, Abdallah A ^a   Mohamed, Badreldin A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Body mass index; C reactive protein; Lipid profile; Obese; Waist circumference; Weight reduction diet

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; FEMALE; HEALTH PROGRAM; HUMAN; MALE; OBESITY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 67649511883     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2009.17.23     Document Type: Article

References (47)

1. Al-Nozha, M.M., M.R. Arafah, Y.Y. Al-Mazrou, M.A. Al-Maatouq and M.Z. Khan et al., 2004. Coronary artery disease in Saudi Arabia. Saudi. Med. J., 25: 1165-1171.
2. Al-Nozha, M.M., Y.Y. Al-Mazrou, M.A. Al-Maatouq, M.R. Arafah and M.Z. Khalil et al., 2005. Obesity in Saudi Arabia. Saudi Med. J., 26: 824-829.
3. Al-Qahtani, D., M. Imtiaz and M. Shareef, 2005. Obesity and cardiovascular risk factors in Saudi adult soldiers. Saudi Med J., 26: 1260-1268.
4. Baltz, M.L., F.C. De-Beer, A. Feinstein, E.A. Munn and C.P. Milstein et al., 1982. Phylogenetic aspects of C-reactive protein and related proteins. Ann. N. Y. Acad. Sci., 389: 49-75.
5. Bastard, J.P., C. Jardel, J. Delattre, B. Hainque, E. Bruckert and F. Oterline, 1999. Evidence for a link between adipose tissue, interleukin-6 content and serum C-reactive protein concentration in obese subjects. Circulation, 99: 2221-2222.
6. Bastard, J.P., C. Jardel, E. Bruckert, P. Blondy and J. Capeau et al., 2000. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese-women after weight loss. J. Clin. Endocr. Metab., 85: 3338-3342.
7. Conway, J.M., S.Z. Yanovski, N.A. Avila and V.S. Hubbard, 1995. Visceral adipose tissue difference in black and white women. Am. J. Clin. Nutr., 61: 765-771.
8. Danesh, J., R. Collins, P. Appleby and R. Peto, 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analysis of prospective studies. J. Am. Med. Assoc., 279: 1477-1482.
9. Després, J.P., S. Moorjani, P.J. Lupien, A. Tremblay, A. Nadeau and C. Bouchard, 1990. Regional distribution of body fat. Plasma lipoproteins and cardiovascular disease. Arteriosclerosis, 10: 497-511.
10. Flegal, K.M., M.D. Carroll, G.L. Ogden and C.L. Johnson, 2002. Prevalence and trends in obesity among US adults 1999-2000. J. Am. Med. Assco., 288: 1723-1727.
11. Fored, E.S. and W.H. Giles, 2000. Serum C-reactive protein and self-reported stroke: Finding from the third national health and nutrition examination survey. Arterioscler. Thromb. Vasc. Biol., 20: 1052-1056.
12. Fried, S.K., D.A. Bunkin and A.S. Greenberg, 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. J. Clin Endocr. Metab., 83: 847-850.
13. Friedewald, W. T., R.I. Levy and D. S. Fredrickson, 1972. Estimation of plasma low-density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem., 18: 499-512.
14. Hak, A.E., C.D. Stehouwer, M.L. Bots, K.H. Polderman and C.G. Schalkwijk et al., 1999. Associations of C-reactive protein with measures of obesity, insulin resistance and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol., 19: 1986-1991.
15. Haverkate, F., S.G. Thompson, S.D. Pyke, J.R. Gallimore and M.B. Pepys, 1997. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 349: 462-466.
16. Isabelle, L., P. Agnès, P. Denis, A. Natalie and B. Peter et al., 2001, Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity. Arterioscl. Throm. Vasc., 21: 961-967.
17. Kissebah, A.H., A.N. Peiris and D. J. Evans, 1989. Biology of regional body fat distribution: Relationship to non-insulin-dependent diabetes mellitus. Diabetes. Metab. Rev., 5: 83-109.
18. Kissebah, A.H. and G.R. Krakower, 1994. Regional adiopsly and morbidty. Physiol. Rev., 74: 761-811.
19. Koenig, W., M. Sund, M. Frohlich, H.G. Fischer and H. Lowel et al., 1999. C-Reactive protein a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) augsburg cohort study, 1984 to 1992. Circulation, 99: 237-242.
20. Kuller, L.H., R.P. Tracy, J. Shaten and E.N. Meilahn, 1996. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple risk factor intervention trial. Am. J. Epidemiol., 144: 537-547.
21. Larsson, B., 1988. Fat Distribution and Risk for Death Myocardial Infarction and Stroke. In: Fat Distribution during Growth and Later Health Outcomes, Bouchard, C. and F.E. Johnston (Eds.). Alan R. Liss, New York, pp: 193-201.
22. Leduc, T.B., D.L. Weiner, J.D. Sipe, S.E. Poulin, M.F. Collins and N. Rifai, 1998. Analytical evaluation of particle enhanced immune phelomtric assays for C-reative protein serum amyloid A and mannose-binding protein in human serum. Ann. Clin. Biochem., 35: 745-753.
23. Liuzzo, G., L.M. Biasucci, J.R. Gallimore, R.L. Grillo and A.G. Rebuzzi et al., 1994. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med., 331: 417-424.
24. Mendall, M.A., P. Patel, L. Ballam, D. Strachan and T.C. Northfield, 1996. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. Br. Med. J., 312: 1061-1065.
25. Mendall, M.A., P. Patel, M. Asante, L. Ballam and J. Morris et al., 1997. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart, 78: 273-277.
26. Mendall, M.A., D.P. Strachan, B.K. Butland, L. Ballam and J. Morris et al., 2000. C-reactive protein relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur. Heart. J., 21: 1584-1590.
27. Mohammed-Ali, V., S. Goodrik, A. Rawesh, D.R. Katz and J.M. Miles et al., 1997. Subcutaneous adipose tissue realeases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocr. Metab., 82: 4196-4200.
28. Montague, C.T., J.B. Prins, L. Sanders, J.E. Digby and S. O'Rahilly, 1997. Depot-and sex-specific differences in human leptin MRNA expression. Implications for the control of regional fat distribution. Diabetes, 46: 342-347.
29. Nesbitt S.D., M.O. Ashaye, N. Stettler, J.M. Sorot and M.T. Goran et al., 2004. Overweight as a risk factor in children a focus on ethnicity. Ethn. Dis., 14: 94-110.
30. Pearson, T.A., G.A. Mensah, R.W. Alexander, J.L. Anderson and R.O. Cannon et al., 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation, 107: 499-511.
31. Pepys, M.B., 1996. The Acute Phase Response and C-Reactive Protein. In: Oxford Textbook of Medicine, Weatheral, D.J., J.G.C. Lendingham, D.A. Warrell (Eds.). Oxford University Press, New York, pp: 1527-1533.
32. Purohit, A., M.W. Ghilchik, L. Duncan, D.Y. Wang, A. Singh, M.M. Walker and M.J. Reed, 1995. Aromatase activity arg malignant breast tissues. J. Clin. Endocr. Metab., 80: 3052-3058.
33. Ridker, P.M., M. Cushman, M.J. Stampfer, R.P. Tracy and C.H. Hennekens, 1997. Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 336: 978-979.
34. Ridker, P.M., 2000. Novel risk factors and markers for coronary disease. Adv. Int. Med., 45: 391-418.
35. Ridker, P.M., C.H. Hennekens, J.G. Buring and N. Rifai, 2000a. C-reactive protein and other marker of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med., 342: 836-843.
36. Ridker, P.M., N. Rifai, M.J. Stampfer and C.H. Hennekens, 2000b. Plasma concentration of interluken-6 and the risk of future myocardial infarction among apparently healthymen. Circulation, 10: 1767-1772.
37. Ridker, P.M., N. Rifai, L. Rose and E. Julis, 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med., 347: 1557-1565.
38. Ridker, P.M., 2003. C-Reactive a simple test to help predict risk of heart attack and stroke. Circulalion, 108: 81-85.
39. Rifai, N., R.D. Tracy and P.M. Ridker, 1999. Clinical efficacy of an-automated high-sensitivity C-reative assay. Clin. Chem., 45: 2136-2141.
40. Rohde, L.E., C.H. Hennekens and P.M. Ridke, 1999. Survey of C-reactive protein and cardiovascular-risk factor in apparently healthy man. Am. J. Cardiol., 84: 1018-1022.
41. Rost, N.S., P.A. Wolf, C.S. Kase, M. Kelly-Hayes and H. Silbershatz et al., 2001. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack, the Framingham Study. Stroke, 32: 2575-2579.
42. Simone, L., P.C. Denis, T. Angelo and D. Jean-Pierre, 1996. A. single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am. J. Clin. Nutr., 64: 685-693.
43. Stevens, J., 1995. Obesity fat patterning and cardiovascular risk. Adv. Exp. Med. Biol., 369: 21-27.
44. Thompson, S.G., J. Kienast, S.D. Pyke, F. Haverkate and J.C. Van-de-Loo, 1995. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European concerted action on thrombosis and disabilities angina pectoris study group. N. Engl. J. Med., 332: 635-641.
45. Tracy, R.P., B.M. Psaty, E. Macy, E.G. Bovill and M. Cushman, 1997a. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscl. Throm. Vasc., 17: 2167-2176.
46. Tracy, R.P., R.N. Lemaitre, B.M. Psaty, D.G. Ives and R.M. Evans et al., 1997b. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Result from the cardiovascular health study and rural health promotion project Arterioscl. Throm. Vasc., 17: 1121-1127.
47. Yudkin, J.S., C.D. Stehouwer, J.J. Emeis and S.W. Coppack, 1999. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscl. Throm. Vasc., 19: 972-978.